semaglutide and tumors GLP-1 drugs cancer: the headline is exciting. The full picture is more nuanced. New research from @ascocancer 2026 shows patients on GLP-1 medications like were up to 50% less likely GLP-1s appear to cut cancer

Uno de los mecanismos clave en la fisiopatologa de la obesidad es la inflamacin crnica de bajo grado, mediada por la produccin de citocinas proinflamatorias y adipocinas que contribuyen al desarrollo de resistencia a la insulina y a una activacin persistente del sistema nervioso simptico, lo que genera un aumento de la presin arterial y favorece la disfuncin endotelial, incrementando el riesgo cardiovascular

Serious adverse events like pancreatitis and gallbladder disease are rare but documented, and semaglutide is contraindicated in patients with personal or family history of medullary thyroid carcinoma

"Appropriate action should be initiated under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, Drugs and Cosmetics Act, 1940 and Rules made thereunder against manufacturers, importers, marketers, or any other entities found in violation," the letter said

p-tau: phosphorylated tau

Kula B, Chen TJ, Kukley M

[DOI] [PMC free article] [PubMed] [Google Scholar] 15.Merchenthaler I., Lane M., Shughrue P